Tianjin Tianyao Pharmaceuticals Co Ltd (600488.SS)

600488.SS on Shanghai Stock Exchange

21 Mar 2018
Change (% chg)

¥0.03 (+0.64%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Tianjin Tianyao Pharmaceuticals Co., Ltd. is a China-based company principally engaged in the research, development and manufacturing of pharmaceutical products. The Company's primary products include corticosteroid bulk pharmaceutical chemicals (BPCs), amino acid BPCs and intermediate, such as dexamethasone, dexamethasone... (more)


Beta: 1.01
Market Cap(Mil.): ¥5,939.86
Shares Outstanding(Mil.): 1,091.89
Dividend: 0.02
Yield (%): 0.39


  600488.SS Industry Sector
P/E (TTM): 61.51 30.94 32.74
EPS (TTM): 0.09 -- --
ROI: 4.17 14.83 14.37
ROE: 3.60 16.33 16.07

BRIEF-Tianjin Tianyao Pharmaceuticals to sell 3.4 pct stake in trust firm

* Says it will sell 3.4 percent stake(33.7 million shares) in trust firm in Tianjin Property Rights Exchange

05 Mar 2018

BRIEF-Tianjin Tianyao Pharmaceuticals signs two API technical development commission contracts worth 3 mln yuan

* Says it and Tianjin Pharmaceuticals Research Institute Co., Ltd signs two technical development commission contracts of API glycyl-glutamine and glycyltyrosine worth 3 million yuan

14 Feb 2018

BRIEF-Tianjin Tianyao Pharmaceuticals production area of API passes FDA CGMP

* Says its API production area passes U.S. FDA CGMP and gets permission to continue selling in U.S. market

29 Nov 2017

BRIEF-Tianjin Tianyao Pharma's board elects chairman

Nov 16 Tianjin Tianyao Pharmaceuticals Co Ltd * Says board elects Chen Jian as chairman Source text in Chinese: http://bit.ly/2zHN0IV Further company coverage: (Reporting by Hong Kong newsroom)

16 Nov 2017

Earnings vs. Estimates